October 6, 2021 -- Hologic has launched its Novodiag on-demand molecular test for infectious diseases and antibiotic resistance in Europe.
Novodiag features real-time polymerase chain reaction and microarray capabilities that allow for multiple pathogens to be identified from a single sample, Hologic said. Its CE-marked IVD test menu includes assays for gastrointestinal infection, antibiotic resistance, and SARS-CoV-2.
The Novodiag European launch comes after Hologic's June purchase of Mobidiag; Novodiag is part of that company's offerings, according to Hologic. Novodiag complements Hologic's Panther laboratory testing system, the company said.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current